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Reactivation disease: the commonest form of 
tuberculous pleural effusion in Edinburgh, 19804991 
H. MOUDGIL, G. SRIDHAR AND A. G. LEITCH* 
Respiratory Medicine Unit, Department of Medicine, University of Edinburgh, City Hospital, Edinburgh and 
Royal Victoria Chest Clinic, Chalmers Hospital, Edinburgh, U.K. 
From 1980-1991 82 (7.2%) of 1134 tuberculosis notifications in Edinburgh were for pleural effusion. Study of 
the available records of 62 cases satisfying defined diagnostic criteria identified 14 cases (6 M, 8 F) with a mean 
age of 27.6 years (range 11-51 years) of primary tuberculous effusion and 25 cases (21 M, 4 F) with a mean 
age of 51 years (range 19-79 years) with pleural effusion due to reactivation disease. Twenty-three patients 
(19 M, 4 F) with a mean age of 48.9 years (range 25-85 years) defied classification. Symptoms, associated and 
diagnostic test findings were similar in all three groups of patients. Parenchymal radiographic shadowing was 
seen in l/14 primary, 16/25 reactivation and 3/25 unclassified pleural effusions. Twenty-three of 30 patients 
treated with corticosteroids showed no residual radiographic abnormality compared to 17/30 not so treated 
(P~0.06). Reactivation disease is currently a commoner cause of tuberculous pleural effusion than primary 
disease in Edinburgh. We suggest that the unclassified cases, so similar in age and sex to the defined 
reactivation disease cases, also represent largely extrapulmonary reactivation disease occurring in middle age. 
Introduction study. All patients included in the analysis fulfilled 
Pleural effusion occurs commonly in association one of the following criteria: ~ 
with primary tuberculosis (l), classically in children I’ 
and adults 3-6 months after infection (2). In devel- 
oped countries tuberculous pleural effusion is more 
2, 
frequent in older age groups suggesting that it may be 3. 
due to reactivation disease (3-5); a recent North 4, 
American study found a median age of 56 years with 
5 (19%) of 26 cases definitely classified as being due to 
5, 
reactivation disease (3). 
Serous pleural effusions, culture positive for 
Mycobacterium tuberculosis. 
Pleural tissue culture positive for M. tuberculosis. 
Serous pleural effusion, sputum culture positive 
for M. tuberculosis. 
We have examined the records of patients notified 6. 
with tuberculous pleural effusions in Edinburgh from 
Pleural biopsy compatible with tuberculosis. 
Lymphocytic pleural fluid, positive tuberculin test 
and compatible clinical picture. 
Pleural effusion, positive tuberculin test, compat- 
ible clinical picture and considered a clinical 
case. 1980-1991 to ascertain whether the condition 
occurred in association with primary infection or was Patients were classified as having a primary tuber- 
due to reactivation of tuberculosis. We also deter- culous effusion if: . 
There was a history of recent tuberculin skin test 
conversion. 
mined the role of corticosteroid therapy in preventing 1. 
residual pleural abnormality (6). 
2. 
Material and Methods 3. 
From 1980 to 1991 82 (7.2%) of 1134 notifications 
There had been recent travel to an area of high 
tuberculosis prevalence. 
There had been recent exposure to an infectious 
case of tuberculosis. 
for tuberculosis in Edinburgh were due to tubercu- 
4. 
lous pleural effusions. Sixty-two available records 5, 
satisfying recent criteria (5) were entered in this 
Received 31 December 1992 and accepted in revised form 26 March 
There was a documented normal chest radiograph 
within the previous year. 
There was hilar lymphadenopathy with or without 
lower-zone non-cavitating infiltrates within the 
previous year. 
1993. Patients were classified as having a reactivation 
Author to whom correspondence should be addressed at: Respira- tuberculous pleural effusion if: 
tory Medicine Unit, City Hospital, Edinburgh, EHlO 5SB, U.K. 1. They had a history of treatment for tuberculosis. 
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Fig. I Age distribution of patients with primary, reactiva- 
tion and unclassified tuberculous pleural effusions. (0) 
total, (H) females. 
2. They had a calcified primary complex on the chest 
radiograph. 
3. They had a documented positive tuberculin test at 
least 1 year prior. 
4. They had cavitating upper lobe or apical segment 
of lower lobe disease. 
Those not defined as primary or reactivation disease 
remained unclassified. 
Details of clinical and radiological findings and test 
results were extracted from the case records. The size 
of the effusion on the radiograph at first presentation 
was classified as small, medium or large as previously 
defined (7). The post-treatment chest radiograph read 
by two observers blind to previous therapy was 
classified as showing either no or some residual 
pleural abnormality. 
Results 
The age and sex distribution of patients in the 
primary, reactivation and unclassified tuberculous 
pleural effusion groups are shown in Fig. 1. 
Fourteen patients (6 M, 8 F) with a mean age of 
27.6 years (range 1 l-5 1 years) had primary tubercu- 
lous pleural effusion; four had recent tuberculin skin 
test conversion; five had returned from a high preva- 
lence area; seven had had recent exposure to an 
infectious case; three had recent normal chest radio- 
graphs and one had hilar adenopathy with parenchy- 
ma1 disease. 
Twenty-five patients (21 M, 4 F) with a mean age 
of 51 years (range 19-79 years) had reactivation 
tuberculous pleural effusion; five had had previous 
chemotherapy for tuberculosis; 12 had radiological 
evidence of past disease; three had had a positive 
tuberculin test at least 1 year previously and nine 
patients had parenchymal disease with cavitating 
lesions confined to the upper lobes or superior 
segment of the lower lobe. 
Twenty-three patients (19 M, 4 F) with a mean age 
of 48.9 years (range 25-85 years) did not meet any of 
the criteria for classification as either primary or 
reactivation tuberculous pleural effusion. 
There were no significant clinical differences 
between the groups with cough, sputum, pleuritic 
chest pain, dyspnoea, weight loss and night sweats 
being the predominant symptoms (Table 1). Smok- 
ing, alcoholism and non-Caucasian ethnicity were the 
commonest associated features. 
Seventy-five per cent of diagnoses had a definite 
bacteriological and/or pathological basis. Of pleural 
aspirates, 4/48 were smear positive and 26/48 culture 
positive for M tuberculosis. Eighty-seven per cent of 
aspirates were straw-coloured and 13% blood- 
stained. Eighty-three per cent of 52 effusions showed 
lymphocytes predominating, 15% were mixed and 2% 
had polymorph predominance. Pleural biopsies were 
taken in 42 cases with caseating granulomata seen in 
25 and acid-fast bacilli in eight cases. 
The radiological findings are shown in Table 2. 
There were more right (32) than left (28), with two 
bilateral effusions. Parenchymal radiographic shad- 
owing was seen in only l/14 primary and 3123 unclas- 
sified disease but in 16125 reactivation disease 
(BO.005 cf. primary and unclassified groups). 
Twenty-three of 30 (77%) of patients treated with 
corticosteroids in addition to chemotherapy showed 
no residual radiographic pleural abnormality com- 
pared to 17/30 (57%) not so treated (P<O.O6). 
Discussion 
The incidence of tuberculous pleural effusions 
among notified cases in this study is similar to that 
reported from Alabama, U.S.A. (4). Classification of 
tuberculous pleural effusions has no therapeutic 
implications but identification of a primary case may 
point to an infectious source case (1). Recognition 
that not all tuberculous pleural effusions are associ- 
ated with primary disease and that reactivation 
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Table I Clinical features of tuberculous pleural effusion 
Primary Reactivation Unclassified Total 
Number 14 25 23 
Mean age (yr) 27.6 51.0 48.9 
Sex 6M:8F 21M:4F 19M:4F 
Cough 12 20 13 
Dyspnoea 6 16 14 
Pleuritic pain 9 16 17 
Weight loss 4 12 11 
Night sweats 5 8 11 
Sputum I 11 11 
Fever 6 4 4 
Asymptomatic 1 0 1 
62 
44.9 
46M:16F 
45 
36 
42 
21 
24 
29 
14 
2 
Associated features 
Alcoholism 1 3 7 11 
Smoking 7 16 18 41 
Diabetes 0 1 0 1 
Other illness 1 1 4 6 
Non-Caucasian 2 4 4 10 
Table 2 Radiological features of tuberculous pleural effusion 
Primary Reactivation Unclassified Total 
Pleural effusion 
Right only 
Left only 
Bilateral 
Total 
8 11 13 32 
6 12 10 28 
0 2 0 2 
14 25 23 
Small 2 10 8 20 
Medium 6 11 I 24 
Large 6 4 8 18 
Total 14 25 23 
Parenchymal disease 
Right only 1 6 2 9 
Left only 0 3 1 4 
Bilateral 0 I 0 7 
Soft shadow 1 9 3 13 
Fibrosis 0 5 0 5 
Cavitation 0 9 0 9 
Adenopathy 1 0 0 1 
disease, as in this study, may be more common, 
emphasizes the need to consider a tuberculous aeti- 
ology when pleural effusion occurs in older age 
groups. 
The mean overall age of our patients (44.9 years) 
was similar to previous studies (3,4) although we had 
a higher percentage of defined reactivation disease 
cases than previously found (3). Many of our patients 
could not be definitely classified as primary or reac- 
tivation disease because we lacked historical data 
concerning skin test and radiological status. The age 
and sex profile of our unclassified group is almost 
identical to that of our reactivation disease group 
of pleural effusions and significantly different from 
the profile of the primary pleural effusions (Fig. 1) 
suggesting that the unclassified group may predomi- 
nantly represent reactivation disease. The relative 
absence of parenchymal disease does not preclude 
reactivation; several of our defined reactivation 
cases of tuberculous pleural effusion did not exhibit 
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Table 3 Proportion of effusions clearing completely in 
each group. Two patients excluded due to death from 
malignancy 
Steroids No steroids 
Primary 
Post-primary 
Unclassified 
Total 
9/10 313 
8/l 1 8/13 
619 6114 
23/30 17130 
(76.7%) (56.7%) 
parenchymal disease (Table 2). There is no a priori 
reason why disease reactivation should not occur in 
the pleural space in the absence of demonstrable 
active pulmonary disease; active pulmonary disease 
does not usually accompany active extrapulmonary 
disease (8). Reactivation disease in the age group of 
our unclassified cases is favoured by the observation 
that the majority of middle-age individuals attending 
a Chest Clinic in Edinburgh have strongly positive 
tuberculin skin test reactions indicating previous 
infection (9). It is also possible that some of our 
defined primary disease cases, in particular the three 
cases qualifying on the basis of a previously normal 
chest radiograph and the five overseas travellers, may 
actually represent reactivation disease. The possibil- 
ity of post primary disease due to a second infection 
also exists, but would be difficult to prove. 
The unilateral tuberculous pleural effusions 
reported in this study confirmed previous findings of 
a right-sided predominance (Table 2) (7). Although 
most such effusions resolve when treated without 
residual effects and lung encasement is rare (l), we 
did find benefit, admittedly equivocal, from corticos- 
teroid therapy in preventing residual pleural abnor- 
mality (Table 3). A recent prospective study also 
failed to confirm to statistically significant levels the 
influence of corticosteroids on the subsequent devel- 
opment of residual pleural thickening, but did 
highlight infrequency of side effects related to the 
corticosteroids amongst these patients, as well as 
confirming significantly both the hastened absorption 
of tuberculous pleural effusions (BO.01) and the 
early resolution of clinical symptoms (PcO.05) in 
cases where corticosteroids were prescribed alongside 
anti-tuberculosis chemotherapy (10). We suggest 
that, in the absence of contraindications, corticoster- 
oids should be routinely prescribed with anti- 
tuberculosis chemotherapy in the management of 
tuberculous pleural effusion. 
In conclusion, we found that in Edinburgh from 
1980-1991 tuberculous pleural effusion due to 
defined reactivation disease was commoner than that 
due to defined primary tuberculous disease. Tubercu- 
lous plural effusion in Edinburgh is therefore com- 
moner in middle age than in younger age groups. We 
also suggest that most of the unclassified cases of 
tuberculous pleural effusion in our study are more 
likely to represent reactivation disease than primary 
disease making reactivation disease over three times 
more common than primary disease. 
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